Lonza
One of the leading global suppliers of active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries.
Launch date
Employees
Market cap
-
Enterprise valuation
€4.3b (Public information from Feb 2021)
Company register number OE016646
Basel Canton of Basel-Stadt (HQ)
Financials
Estimates*
CHF | 2021 |
---|---|
Revenues | 1.7b |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | Spinout | ||
* | $4.7b Valuation: $4.7b | Acquisition | |
* | N/A | CHF400m | Post IPO Debt |
$163m | Post IPO Equity | ||
* | N/A | €1.0b | Post IPO Debt |
Total Funding | - |
Recent News about Lonza
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Lonza
EditACQUISITION by Lonza Jun 2023
ACQUISITION by Lonza May 2008
ACQUISITION by Lonza May 2017
ACQUISITION by Lonza Aug 2016
ACQUISITION by Lonza Jun 2016
ACQUISITION by Lonza Dec 2016
ACQUISITION by Bioceros Sep 2005
ACQUISITION by Lonza May 2017